1 J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Jun 02, 2025
2 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! May 27, 2025
3 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For May 05, 2025
5 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Apr 17, 2025
6 Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Apr 10, 2025
Read More Healthy Spring Constipation With Herbal Remedies, Easy And Convenient To Improve Symptoms Jun 06, 2025
Read More Disease How effective is immunotherapy for gastric cancer? What other treatment options are available for gastric cancer? Jun 05, 2025
Read More Apparatus Nature Medicine publishes results of H-drug combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma Jun 05, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Jun 02, 2025
